Literature DB >> 26685726

Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration.

Diana Arbelaez-Camargo1, Josep Maria Suñé-Negre2, Manel Roig-Carreras3, Encarna García-Montoya2, Pilar Pérez-Lozano2, Montserrat Miñarro-Carmona2, Josep Ramon Ticó-Grau2.   

Abstract

The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensitive and bioadhesive long-acting gel for intraperitoneal administration was done as a tool in the management of pain in abdominal surgeries. The pre-formulation process was conducted by a systematic variation of the concentration of the different polymers, until setting it, in a suitable concentration that allowed an adequate gelation temperature. The poloxamer 407 (P407) was used as the main polymer; hydroxypropyl methylcellulose (HPMC) as the bioadhesive agent and polyvinyl pyrrolidone (PVP) to adjust the gelation temperature and physicochemical properties. The formulations were characterized by gelation temperature, pH, viscosity at 25°C and 37°C, gelation time, density and osmolality. Gelation temperature was decreased when increasing the concentration of hydroxypropyl methylcellulose and poloxamer 407, this effect was also observed when adding lidocaine hydrochloride and dexamethasone sodium phosphate to the formulations. The gelation temperature did not have statistically significant relation with the PVP concentration (P-value of 0.6797), even though, there is a tendency in the gelation temperature by varying it. Between the developed formulations, the 12.5/3.3/0.4% (P407/HPMC/PVP) formulation presents an appropriate gelation temperature, a suitable viscosity for administration by syringe, an adequate and stable pH and osmolality to prevent tissue damage and a correct gelation time that allowed the formation of a prolonged release implant.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioadhesive; Controlled release; Dexamethasone; Intraperitoneal administration; Lidocaine; Poloxamer 407; Thermoreversible gel

Mesh:

Substances:

Year:  2015        PMID: 26685726     DOI: 10.1016/j.ijpharm.2015.12.012

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  In vitro and ex vivo characterisation of an in situ gelling formulation for sustained lidocaine release with potential use following knee arthroplasty.

Authors:  Manisha Sharma; Kaushik Chandramouli; Louise Curley; Beau Pontre; Keryn Reilly; Jacob Munro; Andrew Hill; Simon Young; Darren Svirskis
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

2.  Thermogelling properties of purified poloxamer 407.

Authors:  Amir Fakhari; Marta Corcoran; Alexander Schwarz
Journal:  Heliyon       Date:  2017-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.